Published: Apr 8th, 2015
Diamyd Medical, a Swedish medical research company, annouced that it will join a research initiative launched by JDRF aimed at increasing the understanding of the natural progression of type 1 diabetes in order to transform and accelerate drug development for the disease. Diamyd Medical will contribute data that will be made available to industry and academia partners through an open access database together with similar data from other late stage type 1 diabetes studies.
Published: Apr 1st, 2015
Affiliate diabetes researcher Rhonda Cooper-DeHoff, UF College of Pharmacy, has received of the American College of Cardiology’s 2015 Distinguished Associate Award. Dr. Cooper-DeHoff’s research emphasizes risk factors for Type 2 diabetes and hypertension and improving quality of life for patients diagnosed with combined diabetes and coronary artery disease. Read more.
Published: Mar 17th, 2015
More than 93 million people suffer vision loss from diabetes worldwide. Newly-renovated laboratory space in the UF Department of Ophthalmology will help shed new light on promising treatments and therapies aimed at improving vision health for older adults, particularly those who have diabetes. Diabetic retinopathy is the leading cause of adult blindness in the U.S. Read more.
Published: Mar 10th, 2015
Results from a UF diabetes research project have been selected for presentation at the upcoming American Diabetes Association 75th Scientific Sessions conference in June. Ashby Walker, Ph.D., Department of Health Outcomes and Policy, will present the study findings, entitled “Making a Difference with Behavioral Science.” Read more.
Published: Feb 18th, 2015
University of Florida researchers have received two new multi-year grants totaling nearly $900,000 in funding from the American Diabetes Association; enabling the launch of new scientific studies in Type 1 diabetes and diabetes-linked eye disease. Both awards seek to identify new therapies for early intervention and provide a foundation for future research. Read more.
Published: Feb 17th, 2015
A new treatment that may reverse the effects of the most common type of lupus has shown promising results after undergoing early testing by a team of researchers at UF Health. The studies involved a number of mouse models of the disease and the key experimental findings were also observed in human cells from lupus patients. The results were published in the journal Science Translational Medicine. Read more.
Published: Feb 9th, 2015
NASCAR’s Ryan Reed is teaming with the American Diabetes Association in his second full season in the NASCAR Xfininty Series. Reed, a member of the UF Diabetes Institute Ambassadors Council, will campaign for awareness and educational efforts at all NASCAR Nationwide races this year, as well as at several off track health and wellness initiatives. See website for more details.
Published: Feb 4th, 2015
Mark A. Atkinson, PhD., director of the University of Florida Diabetes Institute, and Alberto Pugliese, M.D., head of the Immunogenetics Program at the University of Miami’s Diabetes Research Institute, were recently honored with the JDRF Mary Tyler Moore and S. Robert Levine Excellence in Clinical Research Award on behalf of the JDRF Network for Pancreatic Organ Donors with Diabetes (nPOD). Learn more.
Published: Feb 3rd, 2015
A new study by University of Florida researchers published in the February issue of Diabetes Care finds that most parents of children with Type 1 diabetes use online health information, including social media, to gain knowledge of the disease. The survey findings can help better establish how much Internet sources affect parents’ level of care for their children, and which ones parents may rely on for accurate information.
Published: Jan 10th, 2015
A collaborative type 1 diabetes study led by researchers from UF and the Institute of Diabetes Research, Helmholtz Zentrum Munchen, in Germany is recognized among JDRF’s Top 10 Research Advances in 2014. The JDRF-funded research has shed more light on the connection between T1D, gut bacteria interactions, and certain viruses.